Intellia Therapeutics (38I.STU) Q3 2026 Earnings

30JulConfirmed
Q2 2026
Next
-0.77
-0.74
-0.72
-0.69

Details

Expected EPS
-0.6980748339999999
Actual EPS
N/A
Surprise EPS
0.7
Surprise Percent
+100%

Description

Intellia Therapeutics (38I.STU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts